Follow The Filings

PBHC Pathfinder Bancorp

Pathfinder Bancorp earnings company data as of 9:59 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 29 Oct EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by PBHC's executives, directors and 10% owners in the last 12 months, from their Form 4s

All PBHC insider trades
  • $67K bought by 4 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Joseph Polniak FVP, General Counsel
    Buy
    $16K 1,000 shares at $15.88 +13% to stake
    Traded Jun 15 Filed Jun 16
    ↗
  2. James A. Dowd CEO
    Buy
    $19K 1,400 shares at $13.69 +7.8% to stake
    Traded Jun 2 Filed Jun 4
    ↗
  3. Adam C. Gagas Director
    Buy
    $27K 1,956 shares at $13.75 +12% to stake
    Traded Feb 12–13 Filed Feb 13
    ↗
  4. David A. Ayoub Director
    Buy
    $5,453 425 shares at $12.83 +2.3% to stake
    Traded Feb 4 Filed Feb 6
    ↗

Also filed in the last 12 months, not counted as buying or selling: 14 option exercises, 1 stock grant, and 1 gift.

SEC filings

Recent issuer filings from EDGAR, 16 shown.

Filed Form Detail Links
8-K 8.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 5.07,9.01 Filing Doc
10-Q Filing Doc
8-K 1.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
DEF 14A Filing Doc
8-K 8.01,9.01 Filing Doc
10-K Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.